# Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

> **NCT00287378** · NA · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 1 (actual)

## Conditions studied

- Asthma
- Allergy

## Interventions

- **DRUG:** omalizumab

## Key facts

- **NCT ID:** NCT00287378
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2009-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287378, "Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00287378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*